Frankfurt
21.10.26 | 15:25
2,340 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.10. | Diaceutics PLC - Precision for All - Capital Markets Webinar | - | RNS | ||
| 12.10. | Diaceutics PLC - Holding(s) in Company | - | RNS | ||
| 07.10. | Diaceutics PLC - Holding(s) in Company | 1 | RNS | ||
| 06.10. | Diaceutics PLC - PDMR Shareholding/SIP and Total Voting Rights | - | RNS | ||
| 28.09. | Diaceutics accelerates growth on precision medicine demand | 2 | The Armchair Trader | ||
| 24.09. | Diaceutics PLC - Diaceutics and Syndax expand Relay partnership | 17 | RNS | ||
| 22.09. | Diaceutics PLC - Interim Results - six months ended 30 June 2026 | - | RNS | ||
| 08.09. | Diaceutics PLC - Notice of Results & Presentations | - | RNS | ||
| DIACEUTICS Aktie jetzt für 0€ handeln | |||||
| 02.09. | Diaceutics PLC - PDMR Shareholding/SIP & Total Voting Rights | 1 | RNS | ||
| 20.08. | Diaceutics und PCC starten Studie zur Konkordanz von NGS-Krebstests | 1 | Investing.com Deutsch | ||
| 20.08. | Diaceutics and PCC launch study on cancer testing accuracy | 1 | Investing.com | ||
| 20.08. | Diaceutics PLC - Diaceutics and PCC launch NGS Concordance Study | - | RNS | ||
| 04.08. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan & TVRs | - | RNS | ||
| 29.07. | Diaceutics PLC - 75% ARR Growth Drives Revenue & Profit Visibility | - | RNS | ||
| 03.07. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVRs | - | RNS | ||
| 25.06. | Diaceutics PLC - Result of AGM | 1 | RNS | ||
| 01.06. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan & TVRs | - | RNS | ||
| 29.05. | Diaceutics PLC - Notice of AGM & Posting of Annual Report | - | RNS | ||
| 26.05. | Diaceutics says order book and pipeline provides confidence for 2026 | 1 | Alliance News | ||
| 26.05. | Diaceutics PLC - Final Results | - | RNS |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,280 | +0,88 % | Atossa Therapeutics: Stammaktien handeln ab sofort gekoppelt mit Contingent Value Rights | ||
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| SENSEONICS | 7,250 | +2,11 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| VYOME | 1,840 | 0,00 % | Vyome Welcomes Jerry Leonard as New Chief Financial Officer | ||
| INTELLIGENT BIO SOLUTIONS | 1,730 | 0,00 % | INTELLIGENT BIO SOLUTIONS INC. - 10-K/A, Annual Report | ||
| PAVMED | 1,790 | -6,38 % | PAVmed Inc.: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results | Veris Health accelerated its commercial engagement with OSU-The James
Veris Health implantable physiological monitor achieved development milestones towards upcoming... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,36 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 55,82 | 0,00 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| AVEANNA HEALTHCARE | 12,990 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,330 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| CONCENTRA GROUP | 39,110 | +0,03 % | Stephens initiates Concentra stock with overweight on health model | ||
| GERRESHEIMER | 32,080 | 0,00 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
15.10.2026 / 13:52 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| BETA BIONICS | 18,390 | -0,05 % | Jefferies initiates Beta Bionics stock coverage with buy rating | ||
| ALIGNMENT HEALTHCARE | 8,445 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Expands Medicare Advantage Plan to Nye County for 2027 | ||
| BILLIONTOONE | 104,58 | -0,09 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |
DIACEUTICS PLC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 2,340 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DIACEUTICS PLC finden Sie auf Wallstreet Online.